PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-44.59%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-54.72%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-96.32%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-96.32%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-962.12%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-940.30%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-940.30%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
2.25%
Share count expansion well above MTDR's 0.62%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
2.25%
Diluted share change of 2.25% while MTDR is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-25.67%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
84.67%
OCF growth above 1.5x MTDR's 31.25%. David Dodd would confirm a clear edge in underlying cash generation.
57.38%
FCF growth 1.25-1.5x MTDR's 45.66%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
-51.03%
Negative 10Y revenue/share CAGR while MTDR stands at 356.47%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-65.61%
Negative 5Y CAGR while MTDR stands at 356.47%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-32.54%
Negative 3Y CAGR while MTDR stands at 68.23%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-64.35%
Negative 10Y OCF/share CAGR while MTDR stands at 494.22%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
160.94%
Below 50% of MTDR's 494.22%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-24.10%
Negative 3Y OCF/share CAGR while MTDR stands at 1137.74%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-5303.17%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-211.83%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-13921.41%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-0.16%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-47.77%
Negative 5Y equity/share growth while MTDR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
9.13%
Below 50% of MTDR's 50.89%. Michael Burry suspects a serious short-term disadvantage in building book value.
23.02%
Stable or rising dividend while MTDR is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
-75.11%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-74.88%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-48.24%
Firm’s AR is declining while MTDR shows 9.39%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
68.33%
Inventory growth well above MTDR's 41.75%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-7.25%
Negative asset growth while MTDR invests at 17.48%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.90%
We have a declining book value while MTDR shows 5.84%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-3.85%
We’re deleveraging while MTDR stands at 24.11%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-0.48%
We cut SG&A while MTDR invests at 53.55%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.